Sahraian MA - Search Results

1

Estimated prevalence and incidence of multiple sclerosis in Iran.

Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Nasr Z. Etemadifar M, et al. Among authors: sahraian ma. Eur Neurol. 2014;72(5-6):370-4. doi: 10.1159/000365846. Epub 2014 Oct 18. Eur Neurol. 2014. PMID: 25341473

2

Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.

Etemadifar M, Fatehi F, Sahraian MA, Borhanihaghighi A, Ardestani PM, Kaji-Esfahani M, Maghzi AH. Etemadifar M, et al. Among authors: sahraian ma. Mult Scler. 2009 Sep;15(9):1126-30. doi: 10.1177/1352458509106612. Mult Scler. 2009. PMID: 19692435

3

Role of MRI in diagnosis and treatment of multiple sclerosis.

Sahraian MA, Eshaghi A. Sahraian MA, et al. Clin Neurol Neurosurg. 2010 Sep;112(7):609-15. doi: 10.1016/j.clineuro.2010.03.022. Epub 2010 Apr 22. Clin Neurol Neurosurg. 2010. PMID: 20417027 Review.

4

Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.

Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Sahraian MA, et al. Eur Neurol. 2010;64(6):331-6. doi: 10.1159/000321649. Epub 2010 Nov 13. Eur Neurol. 2010. PMID: 21071949

5

A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.

Elhami SR, Mohammad K, Sahraian MA, Eftekhar H. Elhami SR, et al. Among authors: sahraian ma. Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20. Neuroepidemiology. 2011. PMID: 21508646

6

Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study.

Harirchian MH, Tekieh AH, Modabbernia A, Aghamollaii V, Tafakhori A, Ghaffarpour M, Sahraian MA, Naji M, Yazdankhah M. Harirchian MH, et al. Among authors: sahraian ma. Eur J Neurol. 2012 Feb;19(2):241-7. doi: 10.1111/j.1468-1331.2011.03476.x. Epub 2011 Jul 19. Eur J Neurol. 2012. PMID: 21771201

7

Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.

Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A. Sahraian MA, et al. Eur J Neurol. 2012 Aug;19(8):1060-9. doi: 10.1111/j.1468-1331.2011.03597.x. Epub 2011 Dec 5. Eur J Neurol. 2012. PMID: 22136455 Review.

8

Multiple sclerosis and pain.

Nick ST, Roberts C, Billiodeaux S, Davis DE, Zamanifekri B, Sahraian MA, Alekseeva N, Munjampalli S, Roberts J, Minagar A. Nick ST, et al. Among authors: sahraian ma. Neurol Res. 2012 Nov;34(9):829-41. doi: 10.1179/1743132812Y.0000000082. Epub 2012 Aug 21. Neurol Res. 2012. PMID: 22909889 Review.

9

Restless legs syndrome in Iranian patients with multiple sclerosis.

Miri S, Rohani M, Sahraian MA, Zamani B, Shahidi GA, Sabet A, Moradi-Lakeh M, Bodaghabadi M. Miri S, et al. Among authors: sahraian ma. Neurol Sci. 2013 Jul;34(7):1105-8. doi: 10.1007/s10072-012-1186-7. Epub 2012 Sep 9. Neurol Sci. 2013. PMID: 22960874

10

Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.

Zahednasab H, Mesbah-Namin SA, Sahraian MA, Balood M, Doosti R. Zahednasab H, et al. Among authors: sahraian ma. Neurosci Lett. 2013 Jun 17;545:46-9. doi: 10.1016/j.neulet.2013.04.014. Epub 2013 Apr 22. Neurosci Lett. 2013. PMID: 23618653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page